TLC BioSciences Corp. Stock Price

TPEX:7924 Community·NT$28.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

7924 Share Price Performance

NT$210.50

0.00 (0.00%)

NT$210.50

0.00 (0.00%)

NT$210.50

Sun, 28 Jun 26

Share Pricen/a

7924 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Very low risk with weak fundamentals.

2 Risks

0 Rewards

View Full Analysis

TLC BioSciences Corp. Key Details

Last Reported Earnings

n/a

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About 7924

Founded: 1997
Employees: n/a
CEO: Zhi-Hong Yeh
WebsiteView website: www.tlcbio.com/en

TLC BioSciences Corp. operates as a clinical-stage biotechnology company that develops and sells lipid-engineered medicines in Taiwan, the United States of America, Europe, and the Cayman Islands. It offers products based on its proprietary LipAD, a drug delivery platforms, including BioSeizer for sustained release; NanoX for targeted delivery; and Genosphere for regenerative medicine. The company's pipeline includes candidates for orthopedics and pain management, metabolic and immune disorders, and infectious diseases. The company was founded in 1997 is based in Taipei, Taiwan.